InsiderSignal.AI

InsiderSignal.ai

KRRO - Korro Bio, Inc.

Insider Purchase by Yang Rick (10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

5 days ago, Yang Rick, serving as 10% owner at Korro Bio, Inc. (KRRO), purchased 207,100 shares at $11.11 per share, for a total transaction value of $2,300,881.00. Following this transaction, Yang Rick now holds 1,297,893 shares of KRRO.

This purchase represents a 19.00% increase in Yang Rick's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 10, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 12, 2026, 2 days after the trade was made.

Korro Bio, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Yang Rick

10%

Rick Yang is a venture capital professional serving as the manager of NEA 17 GP, LLC, which indirectly controls New Enterprise Associates 17, L.P. (NEA 17), a significant investor in SpyGlass Pharma, Inc. (SGP).[[1]](https://www.stocktitan.net/sec-filings/SGP/form-4-spy-glass-pharma-inc-insider-trading-activity-765c05afb450.html)[[5]](https://www.insidermonkey.com/insider-trading/company/spyglass+pharma+inc/1778922/)[[6]](https://insiderinsights.com/free/index.php?s=ticker&o=-1&a=&q=SGP) As a Section 16 reporting person and beneficial owner through NEA 17, he is listed as a corporate insider at SGP, reflecting his influential role in the firm's investment activities.[[1]](https://www.stocktitan.net/sec-filings/SGP/form-4-spy-glass-pharma-inc-insider-trading-activity-765c05afb450.html)[[2]](https://www.ainvest.com/news/insider-purchase-10-owner-director-sgp-bought-3-690-000-shares-2602/) On February 9, 2026, coinciding with SGP's initial public offering, NEA 17 converted its preferred stock (Series B, C-1, C-2, and D) into common shares on a one-for-one basis and purchased an additional 937,500 shares at $16 per share, increasing its holdings to 6,035,038 shares.[[1]](https://www.stocktitan.net/sec-filings/SGP/form-4-spy-glass-pharma-inc-insider-trading-activity-765c05afb450.html)[[2]](https://www.ainvest.com/news/insider-purchase-10-owner-director-sgp-bought-3-690-000-shares-2602/)[[5]](https://www.insidermonkey.com/insider-trading/company/spyglass+pharma+inc/1778922/) Rick Yang disclaims beneficial ownership except to the extent of his pecuniary interest, underscoring his position within the New Enterprise Associates structure.[[1]](https://www.stocktitan.net/sec-filings/SGP/form-4-spy-glass-pharma-inc-insider-trading-activity-765c05afb450.html)

View full insider profile →

Trade Price

$11.11

Quantity

207,100

Total Value

$2,300,881.00

Shares Owned

1,297,893

Trade Date

Tuesday, March 10, 2026

5 days ago

SEC Filing Date

Thursday, March 12, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Korro Bio, Inc.

Company Overview

No company information available
View news mentioning KRRO

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4728351

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime